SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-247566
Filing Date
2017-08-03
Accepted
2017-08-03 16:58:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d409015ds3a.htm S-3/A 119754
2 EX-23.1 d409015dex231.htm EX-23.1 2321
3 EX-23.2 d409015dex232.htm EX-23.2 2976
  Complete submission text file 0001193125-17-247566.txt   126139
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-218949 | Film No.: 171005826
SIC: 2834 Pharmaceutical Preparations